The GH/IGF-1 axis in ageing and longevity – Nature.com

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Advertisement
Nature Reviews Endocrinology volume 9, pages 366–376 (2013)Cite this article
6636 Accesses
360 Citations
137 Altmetric
Metrics details
Secretion of growth hormone (GH), and consequently that of insulin-like growth factor 1 (IGF-1), declines over time until only low levels can be detected in individuals aged ≥60 years. This phenomenon, which is known as the ‘somatopause’, has led to recombinant human GH being widely promoted and abused as an antiageing drug, despite lack of evidence of efficacy. By contrast, several mutations that decrease the tone of the GH/IGF-1 axis are associated with extended longevity in mice. In humans, corresponding or similar mutations have been identified, but whether these mutations alter longevity has yet to be established. The powerful effect of reduced GH activity on lifespan extension in mice has generated the hypothesis that pharmaceutically inhibiting, rather than increasing, GH action might delay ageing. Moreover, mice as well as humans with reduced activity of the GH/IGF-1 axis are protected from cancer and diabetes mellitus, two major ageing-related morbidities. Here, we review data on mouse strains with alterations in the GH/IGF-1 axis and their effects on lifespan. The outcome of corresponding or similar mutations in humans is described, as well as the potential mechanisms underlying increased longevity and the therapeutic benefits and risks of medical disruption of the GH/IGF-1 axis in humans.
Growth hormone (GH) is a potent metabolic hormone that has been touted as a ‘fountain of youth’
Recombinant human (rh) GH and insulin-like growth factor 1 (IGF-1) are approved therapeutics for patients with GH deficiency or primary IGF-1 deficiency, respectively; however, these drugs have been misused
Currently available data do not suggest that rhGH treatment should be used to promote longevity
Lack of GH action in mouse models is associated with extended longevity, but the mechanism underlying the increased lifespan has yet to be established
Given the effects of reduced GH/IGF-1 signalling on lifespan in rodents, decreased GH action might be beneficial for humans, but clinical trials are needed to assess long-term outcome of GH/IGF-1 inhibition
This is a preview of subscription content, access via your institution

Subscribe to this journal
Receive 12 print issues and online access
£139.00 per year
only £11.58 per issue

Rent or buy this article
Prices vary by article type
from$1.95
to$39.95

Prices may be subject to local taxes which are calculated during checkout
John J. Kopchick, Reetobrata Basu, … Vishwajeet Puri
Gherardo Mazziotti, Andrea G. Lania & Ernesto Canalis
C. P. Hedges, B. Shetty, … T. L. Merry
Møller, N & Jørgensen, J. O. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr. Rev. 30, 152–177 (2009).
Article  CAS  PubMed  Google Scholar 
Zadik, Z., Chalew, S. A., McCarter, R. J. Jr, Meistas, M. & Kowarski, A. A. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J. Clin. Endocrinol. Metab. 60, 513–516 (1985).
Article  CAS  PubMed  Google Scholar 
Bartke, A. Growth hormone and aging: a challenging controversy. Clin. Interv. Aging 3, 659–665 (2008).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Rudman, D. et al. Effects of human growth hormone in men over 60 years old. N. Engl. J. Med. 323, 1–6 (1990).
Article  CAS  PubMed  Google Scholar 
Liu, H. et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann. Intern. Med. 146, 104–115 (2007).
Article  PubMed  Google Scholar 
Fontana, L., Partridge, L. & Longo, V. D. Extending healthy life span—from yeast to humans. Science 328, 321–326 (2010).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Snell, G. D. Dwarf, a new Mendelian recessive character of the house mouse. Proc. Natl Acad. Sci. USA 15, 733–734 (1929).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Eicher, E. M. & Beamer, W. G. New mouse dw allele: genetic location and effects on lifespan and growth hormone levels. J. Hered. 71, 187–190 (1980).
Article  CAS  PubMed  Google Scholar 
Li, S. et al. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347, 528–533 (1990).
Article  CAS  PubMed  Google Scholar 
Flurkey, K., Papaconstantinou, J., Miller, R. A. & Harrison, D. E. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc. Natl Acad. Sci. USA 98, 6736–6741 (2001).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Brooks, N. L. et al. Low utilization of circulating glucose after food withdrawal in Snell dwarf mice. J. Biol. Chem. 282, 35069–35077 (2007).
Article  CAS  PubMed  Google Scholar 
Vergara, M., Smith-Wheelock, M., Harper, J. M., Sigler, R. & Miller, R. A. Hormone-treated snell dwarf mice regain fertility but remain long lived and disease resistant. J. Gerontol. A. Biol. Sci. Med. Sci. 59, 1244–1250 (2004).
Article  PubMed  Google Scholar 
Schaible, R. & Gowen, J. W. A new dwarf mouse. Genetics 46, 896 (1961).
Google Scholar 
Buckwalter, M. S., Katz, R. W. & Camper, S. A. Localization of the panhypopituitary dwarf mutation (df) on mouse chromosome 11 in an intersubspecific backcross. Genomics 10, 515–526 (1991).
Article  CAS  PubMed  Google Scholar 
Andersen, B. et al. The Ames dwarf gene is required for Pit-1 gene activation. Dev. Biol. 172, 495–503 (1995).
Article  CAS  PubMed  Google Scholar 
Sornson, M. W. et al. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384, 327–333 (1996).
Article  CAS  PubMed  Google Scholar 
Brown-Borg, H. M., Borg, K. E., Meliska, C. J. & Bartke, A. Dwarf mice and the ageing process. Nature 384, 33 (1996).
Article  CAS  PubMed  Google Scholar 
Bartke, A. et al. Extending the lifespan of long-lived mice. Nature 414, 412 (2001).
Article  CAS  PubMed  Google Scholar 
Panici, J. A. et al. Early life growth hormone treatment shortens longevity and decreases cellular stress resistance in long-lived mutant mice. FASEB J. 24, 5073–5079 (2010).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Krzisnik, C., Grgurić, S. Cvijović, K. & Laron, Z. Longevity of the hypopituitary patients from the island Krk: a follow-up study. Pediatr. Endocrinol. Rev. 7, 357–362 (2010).
PubMed  Google Scholar 
Krzisnik, C. et al. The “little people” of the island of Krk—revisited. Etiology of hypopituitarism revealed. J. Endocr. Genet. 1, 9–19 (1999).
Google Scholar 
Eicher, E. M. & Beamer, W. G. Inherited ateliotic dwarfism in mice. Characteristics of the mutation, little, on chromosome 6. J. Hered. 67, 87–91 (1976).
Article  CAS  PubMed  Google Scholar 
Godfrey, P. et al. GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat. Genet. 4, 227–232 (1993).
Article  CAS  PubMed  Google Scholar 
Donahue, L. R. & Beamer, W. G. Growth hormone deficiency in ‘little’ mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. J. Endocrinol. 136, 91–104 (1993).
Article  CAS  PubMed  Google Scholar 
Salvatori, R. et al. Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J. Clin. Endocrinol. Metab. 84, 917–923 (1999).
CAS  PubMed  Google Scholar 
Aguiar-Oliveira, M. H. et al. Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene. J. Clin. Endocrinol. Metab. 95, 714–721 (2010).
Article  CAS  PubMed  Google Scholar 
Baumann, G. & Maheshwari, H. The Dwarfs of Sindh: severe growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene. Acta Paediatr. Suppl. 423, 33–38 (1997).
Article  CAS  PubMed  Google Scholar 
Maheshwari, H. G., Silverman, B. L., Dupuis, J. & Baumann, G. Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: dwarfism of Sindh. J. Clin. Endocrinol. Metab. 83, 4065–4074 (1998).
CAS  PubMed  Google Scholar 
Besson, A. et al. Reduced longevity in untreated patients with isolated growth hormone deficiency. J. Clin. Endocrinol. Metab. 88, 3664–3667 (2003).
Article  CAS  PubMed  Google Scholar 
Dobbs, A. K. et al. Cutting edge: a hypomorphic mutation in Igβ (CD79b) in a patient with immunodeficiency and a leaky defect in B cell development. J. Immunol. 179, 2055–2059 (2007).
Article  CAS  PubMed  Google Scholar 
Zhou, Y. et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc. Natl Acad. Sci. USA 94, 13215–13220 (1997).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Laron, Z. & Kopchick, J. (Eds) Laron Syndrome—From Man to Mouse (Springer, 2011).
Book  Google Scholar 
List, E. O. et al. Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR^−/−) mouse. Endocr. Rev. 32, 356–386 (2011).
Article  CAS  PubMed  Google Scholar 
Coschigano, K. T., Clemmons, D., Bellush, L. L. & Kopchick, J. J. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141, 2608–2613 (2000).
Article  CAS  PubMed  Google Scholar 
Coschigano, K. T. et al. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin and IGF-1 levels and increased lifespan. Endocrinology 144, 3799–3810 (2003).
Article  CAS  PubMed  Google Scholar 
Berryman, D. E. et al. Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm. IGF Res. 14, 309–318 (2004).
Article  CAS  PubMed  Google Scholar 
Berryman, D. E. et al. Two-year body composition analyses of long-lived GHR null mice. J. Gerontol. A. Biol. Sci. Med. Sci. 65, 31–40 (2010).
Article  CAS  PubMed  Google Scholar 
Methuselah Foundation. Latest Mprize Winners [online], (2013)
Bonkowski, M. S., Rocha, J. S., Masternak, M. M., Al Regaiey, K. A. & Bartke, A. Targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction. Proc. Natl Acad. Sci. USA 103, 7901–7905 (2006).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Laron, Z. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958–2003. J. Clin. Endocrinol. Metab. 89, 1031–1044 (2004).
Article  CAS  PubMed  Google Scholar 
Laron, Z., Avitzur, Y. & Klinger, B. Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment. Metabolism 44 (Suppl. 4), 113–118 (1995).
Article  CAS  PubMed  Google Scholar 
Laron, Z. The GH–IGF1 axis and longevity. The paradigm of IGF1 deficiency. Hormones (Athens) 7, 24–27 (2008).
Article  Google Scholar 
Rosenbloom, A. L., Guevara Aguirre, J., Rosenfeld, R. G. & Fielder, P. J. The little women of Loja—growth hormone-receptor deficiency in an inbred population of southern Ecuador. N. Engl. J. Med. 323, 1367–1374 (1990).
Article  CAS  PubMed  Google Scholar 
Guevara-Aguirre, J. et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 3, 70ra13 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Steuerman, R., Shevah, O. & Laron, Z. Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies. Eur. J. Endocrinol. 164, 485–489 (2011).
Article  CAS  PubMed  Google Scholar 
Chen, W. Y., Wight, D. C., Mehta, B. V., Wagner, T. E. & Kopchick, J. J. Glycine 119 of bovine growth hormone is critical for growth-promoting activity. Mol. Endocrinol. 5, 1845–1852 (1991).
Article  CAS  PubMed  Google Scholar 
Chen, W. Y., White, M. E., Wagner, T. E. & Kopchick, J. J. Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice. Endocrinology 129, 1402–1408 (1991).
Article  CAS  PubMed  Google Scholar 
Palmiter, R. D. et al. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 300, 611–615 (1982).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Palmer, A. J. et al. Age-related changes in body composition of bovine growth hormone transgenic mice. Endocrinology 150, 1353–1360 (2009).
Article  CAS  PubMed  Google Scholar 
Bartke, A. Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology 78, 210–216 (2003).
Article  CAS  PubMed  Google Scholar 
Quaife, C. J. et al. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology 124, 40–48 (1989).
Article  CAS  PubMed  Google Scholar 
Chanson, P. & Salenave, S. Acromegaly. Orphanet J. Rare Dis. 3, 17, (2008).
Article  PubMed  PubMed Central  Google Scholar 
Eugster, E. A. & Pescovitz, O. H. Gigantism. J. Clin. Endocrinol. Metab. 84, 4379–4384 (1999).
Article  CAS  PubMed  Google Scholar 
Katznelson, L. Alterations in body composition in acromegaly. Pituitary 12, 136–142 (2008).
Article  CAS  Google Scholar 
Ayuk, J. & Sheppard, M. C. Does acromegaly enhance mortality? Rev. Endocr. Metab. Disord. 9, 33–39 (2008).
Article  PubMed  Google Scholar 
Melmed, S. Acromegaly pathogenesis and treatment. J. Clin. Invest. 119, 3189–3202 (2009).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Holdaway, I. M., Bolland, M. J. & Gamble, G. D. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur. J. Endocrinol. 159, 89–95 (2008).
Article  CAS  PubMed  Google Scholar 
Liu, J. P., Baker, J., Perkins, A. S., Robertson, E. J. & Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75, 59–72 (1993).
CAS  PubMed  Google Scholar 
Sjögren, K. et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl Acad. Sci. USA 96, 7088–7092 (1999).
Article  PubMed  PubMed Central  Google Scholar 
Yakar, S. et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl Acad. Sci. USA 96, 7324–7329, (1999).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Svensson, J. et al. Liver-derived IGF-I regulates mean life span in mice. PLoS ONE 6, e22640 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Novosyadlyy, R. & Leroith, D. Insulin-like growth factors and insulin: at the crossroad between tumor development and longevity. J. Gerontol. A. Biol. Sci. Med. Sci. 67, 640–651 (2012).
Article  CAS  PubMed  Google Scholar 
Li, Q., Ceylan-Isik, A. F., Li, J. & Ren, J. Deficiency of insulin-like growth factor 1 reduces sensitivity to aging-associated cardiomyocyte dysfunction. Rejuvenation Res. 11, 725–733 (2008).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Conover, C. A. et al. Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 131, 1187–1194 (2004).
Article  CAS  PubMed  Google Scholar 
Conover, C. A. & Bale, L. K. Loss of pregnancy-associated plasma protein A extends lifespan in mice. Aging Cell 6, 727–729 (2007).
Article  CAS  PubMed  Google Scholar 
Conover, C. A. Key questions and answers about pregnancy-associated plasma protein-A. Trends Endocrinol. Metab. 23, 242–249 (2012).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Conover, C. A. et al. Longevity and age-related pathology of mice deficient in pregnancy-associated plasma protein-A. J. Gerontol. A Biol. Sci. Med. Sci. 65, 590–599 (2010).
Article  CAS  PubMed  Google Scholar 
Holzenberger, M. et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421, 182–187 (2003).
Article  CAS  PubMed  Google Scholar 
Bokov, A. F. et al. Does reduced IGF-1R signaling in Igf1r^+/− mice alter aging? PLoS ONE 6, e26891 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Ladiges, W. et al. Lifespan extension in genetically modified mice. Aging Cell 8, 346–352 (2009).
Article  CAS  PubMed  Google Scholar 
Tazearslan, C., Huang, J., Barzilai, N. & Suh, Y. Impaired IGF1R signaling in cells expressing longevity-associated human IGF1R alleles. Aging Cell 10, 551–554 (2011).
Article  CAS  PubMed  Google Scholar 
Suh, Y. et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc. Natl Acad. Sci. USA 105, 3438–3442 (2008).
Article  PubMed  PubMed Central  Google Scholar 
Kurosu, H. et al. Suppression of aging in mice by the hormone Klotho. Science 309, 1829–1833 (2005).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Wolf, I. et al. Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene 27, 7094–7105 (2008).
Article  CAS  PubMed  Google Scholar 
Kuro-o, M. et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45–51 (1997).
Article  CAS  PubMed  Google Scholar 
Withers, D. J. et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900–904 (1998).
Article  CAS  PubMed  Google Scholar 
Previs, S. F., Withers, D. J., Ren, J. M., White, M. F. & Shulman, G. I. Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J. Biol. Chem. 275, 38990–38994 (2000).
Article  CAS  PubMed  Google Scholar 
Tamemoto, H. et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372, 182–186 (1994).
Article  CAS  PubMed  Google Scholar 
Selman, C. et al. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J. 22, 807–818 (2008).
Article  CAS  PubMed  Google Scholar 
Selman, C., Partridge, L. & Withers, D. J. Replication of extended lifespan phenotype in mice with deletion of insulin receptor substrate 1. PLoS ONE 6, e16144 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Taguchi, A., Wartschow, L. M. & White, M. F. Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science 317, 369–372 (2007).
Article  CAS  PubMed  Google Scholar 
Selman, C., Lingard, S., Gems, D., Partridge, L. & Withers, D. J. Comment on “Brain IRS2 signaling coordinates life span and nutrient homeostasis”. Science 320, 1012 (2008).
Article  CAS  PubMed  Google Scholar 
Barbieri, M. et al. The IRS2 Gly1057Asp variant is associated with human longevity. J. Gerontol. A. Biol. Sci. Med. Sci. 65, 282–286 (2010).
Article  CAS  PubMed  Google Scholar 
Ranieri, S. C. et al. Mammalian life-span determinant p66shcA mediates obesity-induced insulin resistance. Proc. Natl Acad. Sci. USA 107, 13420–13425 (2010).
Article  PubMed  PubMed Central  Google Scholar 
Migliaccio, E. et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402, 309–313 (1999).
Article  CAS  PubMed  Google Scholar 
Bartke, A. Healthy aging: is smaller better?—a mini-review. Gerontology 58, 337–343 (2012).
Article  PubMed  Google Scholar 
Tran, T. T., Yamamoto, Y., Gesta, S. & Kahn, C. R. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab. 7, 410–420 (2008).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Kregel, K. C. & Zhang, H. J. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R18–R36 (2007).
Article  CAS  PubMed  Google Scholar 
Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232–236 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Haruna, Y. et al. Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc. Natl Acad. Sci. USA 104, 2331–2336 (2007).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Harper, J. M., Durkee, S. J., Dysko, R. C., Austad, S. N. & Miller, R. A. Genetic modulation of hormone levels and life span in hybrids between laboratory and wild-derived mice. J. Gerontol. A. Biol. Sci. Med. Sci. 61, 1019–1029 (2006).
Article  PubMed  Google Scholar 
Murakami, S. Stress resistance in long-lived mouse models. Exp. Gerontol. 41, 1014–1019 (2006).
Article  CAS  PubMed  Google Scholar 
Fulda S., Gorman A. M., Hori O. & Samali A. Cellular stress responses: cell survival and cell death. Int. J. Cell Biol. 2010, 214074 (2010).
PubMed  PubMed Central  Google Scholar 
Wullschleger S, Loewith R. & Hall M. N. TOR signaling in growth and metabolism. Cell 124, 471–484 (2006).
Article  CAS  PubMed  Google Scholar 
Zoncu R., Efeyan A. & Sabatini D. M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21–35 (2011).
Article  CAS  PubMed  Google Scholar 
Pérez, V. I. et al. Is the oxidative stress theory of aging dead? Biochim. Biophys. Acta 1790, 1005–1014 (2009).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Amador-Noguez, D. et al. Alterations in xenobiotic metabolism in the long-lived Little mice. Aging Cell 6, 453–470 (2007).
Article  CAS  PubMed  Google Scholar 
Chhabra, Y., Waters, M. J. & Brooks, A. J. Role of the growth hormone-IGF-1 axis in cancer. Expert Rev. Endocrinol. Metab. 6, 71–84 (2011).
Article  CAS  PubMed  Google Scholar 
Ikeno, Y., Bronson, R. T., Hubbard, G. B., Lee, S. & Bartke, A. Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity. J. Gerontol. A. Biol. Sci. Med. Sci. 58, 291–296 (2003).
Article  PubMed  Google Scholar 
Majeed, N. et al. A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model. Oncogene 24, 4736–4740 (2005).
Article  CAS  PubMed  Google Scholar 
Ikeno, Y. et al. Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice. J. Gerontol. A. Biol. Sci. Med. Sci. 64, 522–529 (2009).
Article  CAS  PubMed  Google Scholar 
Pollak, M., Blouin, M. J., Zhang, J. C. & Kopchick, J. J. Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist. Br. J. Cancer 85, 428–430 (2001).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Harrison, D. E. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392–395 (2009).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Wang, M. & Miller, R. A. Augmented autophagy pathways and MTOR modulation in fibroblasts from long-lived mutant mice. Autophagy 8, (2012).
Thorner, M. O. Statement by the Growth Hormone Research Society on the GH/IGF-I axis in extending health span. J. Gerontol. A. Biol. Sci. Med. Sci. 64, 1039–1044 (2009).
Article  CAS  PubMed  Google Scholar 
Elbornsson M. et al. Fifteen years of growth hormone (GH) replacement improves body composition and cardiovascular risk factors. Eur. J. Endocrinol. http://dx.doi.org/10.1530/EJE-12-1083.
Blackman M. R. et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 288, 2282–2292 (2002).
Article  CAS  PubMed  Google Scholar 
Vestergaard, P. et al. Local administration of growth hormone stimulates tendon collagen synthesis in elderly men. J. Appl. Physiol. 113, 1432–1438 (2012).
Article  CAS  PubMed  Google Scholar 
Trainer, P. J. ACROSTUDY: the first 5 years. Eur. J. Endocrinol. 161 (Suppl. 1), S19–S24 (2009).
Article  CAS  PubMed  Google Scholar 
van der Lely, A. J. et al. Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY. J. Clin. Endocrinol. Metab. 97, 1589–1597 (2012).
Article  CAS  PubMed  Google Scholar 
Parkinson C. et al. A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal. J. Clin. Endocrinol. Metab. 4, 1797–1804 (2002).
Article  Google Scholar 
Liang, H. et al. Genetic mouse models of extended lifespan. Exp. Gerontol. 38, 1353–1364, (2003).
Article  CAS  PubMed  Google Scholar 
Yakar, S. et al. Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 50, 1110–1118 (2001).
Article  CAS  PubMed  Google Scholar 
McCay, C. M., Crowell, M. F. & Maynard, L. A. The effect of retarded growth upon the length of the life span and upon the ultimate body size. 1935. Nutrition 5, 155–171 (1989).
CAS  PubMed  Google Scholar 
Katic M. & Kahn C. R. The role of insulin and IGF-1 signaling in longevity. Cell. Mol. Life Sci. 62, 320–343 (2005).
Article  CAS  PubMed  Google Scholar 
Omodei, D. & Fontana, L. Calorie restriction and prevention of age-associated chronic disease. FEBS Lett. 585, 1537–1542 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Larson-Meyer, D. E. et al. Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring) 16, 1355–1362 (2008).
Article  CAS  Google Scholar 
Heilbronn, L. K. et al. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA 295, 1539–1548 (2006).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Colman, R. J. et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325, 201–204 (2009).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Mattison, J. A. et al. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 489, 318–321 (2012).
Article  CAS  PubMed  Google Scholar 
Download references
The authors thank J. Sattler at Ohio University Heritage College for Osteopathic Medicine, Athens, OH, USA for taking the mouse photograph. J. J. Kopchick is supported by the State of Ohio’s Eminent Scholar Program, which includes a gift from Milton and Lawrence Goll, by AMVETS, and by NIH (P01AG031736).
Edison Biotechnology Institute, Ohio University, 1 Water Tower Drive, The Ridges, Athens, 45701, OH, USA
Riia K. Junnila, Edward O. List, Darlene E. Berryman & John J. Kopchick
Department of Radiology, O’Bleness Hospital, 55 Hospital Drive, Athens, 45701, OH, USA
John W. Murrey
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
R. K. Junnila and J. W. Murrey researched the data for the article. R. K. Junnila and J. J. Kopchick contributed equally to writing the article. All authors provided a substantial contribution to discussions of the content and reviewed and/or edited the manuscript before submission.
Correspondence to John J. Kopchick.
J. J. Kopchick declares that he is an inventor of US patent 5350836 entitled ‘Growth hormone antagonists’. The other authors declare no competing interests.
Reprints and permissions
Junnila, R., List, E., Berryman, D. et al. The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol 9, 366–376 (2013). https://doi.org/10.1038/nrendo.2013.67
Download citation
Published: 16 April 2013
Issue Date: June 2013
DOI: https://doi.org/10.1038/nrendo.2013.67
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative
Cell Communication and Signaling (2023)
Nature Genetics (2023)
GeroScience (2023)
Pituitary (2023)
Scientific Reports (2022)

Advertisement
Nature Reviews Endocrinology (Nat Rev Endocrinol) ISSN 1759-5037 (online) ISSN 1759-5029 (print)
© 2024 Springer Nature Limited
Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

source

About The Author

admin

See author's posts